CLINICAL_TRIALS
trial_result
· 2024-06-17
Clinical Trial Update: A Study of Replagal in Treatment-naïve Adults With Fabry Disease [Phase 3]
Summary
This clinical trial update reports that the Phase 3 study of Replagal (agalsidase alfa) in treatment-naïve adults with Fabry disease was terminated, with result…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Fabry Disease | Phase 3 | Status: TERMINATED | Results posted: 2024-06-17